Baroreflex sensitivity and oxidative stress in the LDL receptor knockout mice

Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie
Cristina CamposKatya Rigatto

Abstract

This study aims at observing the effect of low-density lipoprotein (LDL) receptor deficiency in cholesterol blood levels, baroreflex sensitivity (BRS), nitric oxide (NO) bioavailability, and oxidative stress. The lack of LDL receptors in mice significantly increased the cholesterol blood levels (179+/-35 vs. 109+/-13mg/dL) in the knockout (KO) mice compared to control. There was no difference in basal mean arterial pressure and heart rate between the groups. However, in KO mice the BRS was significantly attenuated and the antioxidant enzyme activities, measured in erythrocytes and heart, were significantly decreased. On the other hand, the oxidative damage measured by chemiluminescence and carbonyls was increased, while total plasma nitrate levels were lower in KO mice, indicating a decrease in NO availability. In conclusion, these results indicate that the lack of LDL receptor increased cholesterol blood levels, induced oxidative stress and decreased BRS.

References

Jan 1, 1992·JAMA : the Journal of the American Medical Association·G D SmithG Rose
Nov 1, 1991·Hypertension·A Zanchetti, G Mancia
Dec 1, 1990·The Journal of Clinical Investigation·R L MinorD G Harrison
Jan 1, 1989·Clinical and Experimental Pharmacology & Physiology. Supplement·E M Krieger
Sep 1, 1989·Angiology·K Prasad, J Kalra
May 20, 1985·FEBS Letters·S L Marklund
Jan 1, 1971·Annals of Internal Medicine·W B KannelP M McNamara
Jan 1, 1984·Methods in Enzymology·L Flohé, W A Günzler
Jan 6, 1995·The Journal of Biological Chemistry·J K LiaoS L Clark
Jun 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·A M Lefer, X L Ma
Jan 1, 1994·Methods in Enzymology·A Z Reznick, L Packer
May 1, 1994·The Journal of Clinical Investigation·S IshibashiD K Burns
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·C R WhiteB A Freeman
Jun 1, 1993·The Journal of Clinical Investigation·Y OharaD G Harrison
Jun 27, 1998·Biochemical and Biophysical Research Communications·V N Trieu, F M Uckun
Jan 7, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M C Irigoyen, E M Krieger
Jan 27, 1999·Methods in Enzymology·D L GrangerJ B Weinberg
Dec 22, 1999·Journal of Cardiovascular Pharmacology·L J IgnarroC Napoli
Mar 17, 2000·Circulation Research·K K GriendlingM Ushio-Fukai
Mar 29, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·S MeratP D Reaven
Aug 19, 2000·Hypertension·S ChowdharyJ N Townend
Aug 24, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M IemitsuM Matsuda
Feb 24, 2001·Journal of the American College of Cardiology·M Rodriguez-PorcelL O Lerman
Sep 19, 2001·Clinical and Experimental Pharmacology & Physiology·J S BennettsD J McKitrick
Nov 12, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Hiroshi AzumiMitsuhiro Yokoyama
Jun 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Seiichi KobayashiMitsuhiro Yokoyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.